SE7413832L - - Google Patents

Info

Publication number
SE7413832L
SE7413832L SE7413832A SE7413832A SE7413832L SE 7413832 L SE7413832 L SE 7413832L SE 7413832 A SE7413832 A SE 7413832A SE 7413832 A SE7413832 A SE 7413832A SE 7413832 L SE7413832 L SE 7413832L
Authority
SE
Sweden
Application number
SE7413832A
Other versions
SE415761B (sv
Inventor
R A Archer
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of SE7413832L publication Critical patent/SE7413832L/xx
Publication of SE415761B publication Critical patent/SE415761B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78—Ring systems having three or more relevant rings
    • C07D311/80—Dibenzopyrans; Hydrogenated dibenzopyrans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/703—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups
    • C07C49/747—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups containing six-membered aromatic rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Cosmetics (AREA)
SE7413832A 1973-11-05 1974-11-04 Forfarande for framstellning av hexahydro-dibenso(b,d)pyran-9-on-derivat med terapeutisk verkan SE415761B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US413009A US3928598A (en) 1973-11-05 1973-11-05 Hexahydro-dibenzo{8 b,d{9 pyran-9-ones as an anti-anxiety drug

Publications (2)

Publication Number Publication Date
SE7413832L true SE7413832L (el) 1975-05-06
SE415761B SE415761B (sv) 1980-10-27

Family

ID=23635412

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7413832A SE415761B (sv) 1973-11-05 1974-11-04 Forfarande for framstellning av hexahydro-dibenso(b,d)pyran-9-on-derivat med terapeutisk verkan

Country Status (25)

Country Link
US (1) US3928598A (el)
JP (1) JPS6033834B2 (el)
AR (1) AR206409A1 (el)
AT (1) AT337178B (el)
BE (1) BE821719A (el)
BG (1) BG25995A3 (el)
CA (1) CA1029383A (el)
CH (1) CH611290A5 (el)
CS (1) CS193506B2 (el)
DD (1) DD116229A5 (el)
DE (1) DE2451932C2 (el)
DK (1) DK136718B (el)
ES (1) ES431675A1 (el)
FR (1) FR2249663B1 (el)
GB (1) GB1487636A (el)
HU (1) HU169192B (el)
IE (1) IE40025B1 (el)
IL (1) IL45662A (el)
NL (1) NL180979C (el)
PH (1) PH10476A (el)
PL (2) PL100502B1 (el)
SE (1) SE415761B (el)
SU (1) SU515457A3 (el)
YU (1) YU36946B (el)
ZA (1) ZA745794B (el)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4051152A (en) * 1976-01-07 1977-09-27 Sharps Associates Oxo C-ring benzopyrans
US4087546A (en) * 1976-02-17 1978-05-02 Eli Lilly And Company Hexahydro-dibenzo[b,d]pyran-9-ones as antiasthmatic drugs
US4087545A (en) * 1976-02-17 1978-05-02 Eli Lilly And Company Hexahydro-dibenzo[b,d]pyran-9-ones as antiemetic drugs
SE7704749L (sv) * 1976-05-17 1977-12-05 Pfizer Kinoliner och forfarande och mellanprodukter for framstellning derav
US4054581A (en) * 1976-07-06 1977-10-18 Eli Lilly And Company Preparation of cis-1-hydroxy-3-substituted-6,6-dimethyl-6,6a,7,8,10,10a-hexahydro-9H-dibenzo[b,d]pyran-9-ones and intermediates therefor
US4102902A (en) * 1976-11-10 1978-07-25 Eli Lilly And Company Stereoselective preparation of hexahydro dibenzopyranones and intermediates therefor
US4351833A (en) * 1980-07-28 1982-09-28 Pfizer Inc. 9-Amino-1-hydroxyoctahydrobenzo[c]quinolines and derivatives thereof as analgesics and anti-emetics
US4309545A (en) * 1980-07-28 1982-01-05 Pfizer Inc. Oximino-1-hydroxyoctahydrobenzo[c]quinolines and derivatives thereof
US5498419A (en) * 1994-06-03 1996-03-12 Pars; Harry G. Fumarate salt of 4-(diethyl-3-(1-methyloctyl)-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-dibenzo[b,d]pyran-1-ol, 4-(diethyl-amino) butyric
DE69910373T2 (de) * 1998-05-04 2004-04-01 The University Of Connecticut, Farmington Analgetische und immunomodulierende cannabinoiden
US7897598B2 (en) * 1998-06-09 2011-03-01 Alexandros Makriyannis Inhibitors of the anandamide transporter
US7589220B2 (en) * 1998-06-09 2009-09-15 University Of Connecticut Inhibitors of the anandamide transporter
US7276613B1 (en) 1998-11-24 2007-10-02 University Of Connecticut Retro-anandamides, high affinity and stability cannabinoid receptor ligands
US7161016B1 (en) 1998-11-24 2007-01-09 University Of Connecticut Cannabimimetic lipid amides as useful medications
US6566560B2 (en) 1999-03-22 2003-05-20 Immugen Pharmaceuticals, Inc. Resorcinolic compounds
DE60033834T2 (de) 1999-10-18 2007-11-15 The University Of Connecticut, Farmington Für periphäre cannabinoid-rezeptoren selektive liganden
US8084467B2 (en) * 1999-10-18 2011-12-27 University Of Connecticut Pyrazole derivatives as cannabinoid receptor antagonists
US7119108B1 (en) * 1999-10-18 2006-10-10 University Of Connecticut Pyrazole derivatives as cannabinoid receptor antagonists
US6943266B1 (en) * 1999-10-18 2005-09-13 University Of Connecticut Bicyclic cannabinoid agonists for the cannabinoid receptor
US7741365B2 (en) * 1999-10-18 2010-06-22 University Of Connecticut Peripheral cannabinoid receptor (CB2) selective ligands
US6900236B1 (en) 1999-10-18 2005-05-31 University Of Connecticut Cannabimimetic indole derivatives
US7393842B2 (en) * 2001-08-31 2008-07-01 University Of Connecticut Pyrazole analogs acting on cannabinoid receptors
AU2001296402A1 (en) * 2000-09-28 2002-04-08 Immugen Pharmaceuticals, Inc. Methods and compounds for inhibiting eicosanoid metabolism and platelet aggregation
AU2002213429A1 (en) * 2000-09-28 2002-04-08 Immugen Pharmaceuticals, Inc. Antiviral methods and compounds
JP2004532185A (ja) * 2001-01-26 2004-10-21 ユニバーシティ オブ コネチカット 新規なカンナビミメティックリガンド
DE60237431D1 (de) 2001-01-29 2010-10-07 Univ Connecticut Rezeptor-selektive cannabimimetische aminoalkylindole
JP4312594B2 (ja) * 2001-07-13 2009-08-12 ユニバーシティ オブ コネチカット 新規な二環式及び三環式カンナビノイド
WO2003035005A2 (en) * 2001-10-26 2003-05-01 University Of Connecticut Heteroindanes: a new class of potent cannabimimetic ligands
AU2003214226A1 (en) * 2002-03-18 2003-10-08 Immugen Pharmaceuticals, Inc. Topical formulations of resorcinols and cannibinoids and methods of use
CN1678303A (zh) 2002-08-23 2005-10-05 康涅狄格大学 具有治疗作用的酮类大麻类

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3636058A (en) * 1966-03-25 1972-01-18 Hoffmann La Roche 7 10 - dihydro - 3 - alkyl - 6h - dibenzo(b d) pyran-6 9(8h)-diones and 5-hydroxy-7-alkyl-4-chromanones
US3507885A (en) * 1966-03-25 1970-04-21 Hoffmann La Roche 3-alkyl-6h-dibenzo(b,d)pyrans

Also Published As

Publication number Publication date
BG25995A3 (bg) 1979-01-12
PL100502B1 (pl) 1978-10-31
DK136718B (da) 1977-11-14
JPS5082073A (el) 1975-07-03
CS193506B2 (en) 1979-10-31
DK573174A (el) 1975-07-07
ES431675A1 (es) 1977-04-16
NL7414437A (nl) 1975-05-07
US3928598A (en) 1975-12-23
SU515457A3 (ru) 1976-05-25
JPS6033834B2 (ja) 1985-08-05
BE821719A (fr) 1975-04-30
ZA745794B (en) 1976-04-28
CH611290A5 (el) 1979-05-31
ATA886274A (de) 1976-10-15
SE415761B (sv) 1980-10-27
NL180979B (nl) 1987-01-02
FR2249663A1 (el) 1975-05-30
YU36946B (en) 1984-08-31
CA1029383A (en) 1978-04-11
AU7329074A (en) 1976-03-18
AT337178B (de) 1977-06-10
IL45662A0 (en) 1974-11-29
DD116229A5 (el) 1975-11-12
FR2249663B1 (el) 1978-03-24
PH10476A (en) 1977-05-11
DE2451932C2 (de) 1983-09-29
IE40025B1 (en) 1979-02-28
IL45662A (en) 1978-03-10
GB1487636A (en) 1977-10-05
DK136718C (el) 1978-04-24
IE40025L (en) 1975-05-05
NL180979C (nl) 1987-06-01
AR206409A1 (es) 1976-07-23
DE2451932A1 (de) 1975-05-07
PL94965B1 (el) 1977-09-30
YU261974A (en) 1982-06-18
HU169192B (el) 1976-10-28

Similar Documents

Publication Publication Date Title
AU476761B2 (el)
FR2249663B1 (el)
AR201229Q (el)
AR199451A1 (el)
AU477823B2 (el)
AU477824B2 (el)
AR196382A1 (el)
AR197627A1 (el)
AU471461B2 (el)
AR200885A1 (el)
AR200256A1 (el)
AR195948A1 (el)
AR195311A1 (el)
AU476873B1 (el)
AR196212Q (el)
AR196123Q (el)
CH566926A5 (el)
CH562498A5 (el)
CH560529A5 (el)
CH560069A5 (el)
CH1128074A4 (el)
BG22056A3 (el)
AU481697A (el)
AU479903A (el)
AU479422A (el)

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7413832-2

Effective date: 19941210

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 7413832-2

Format of ref document f/p: F